PA
AMRX icon

Parallel Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

Parallel Advisors’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.4K Sell
714
-7
-1% -$96 ﹤0.01% 2843
2026
Q1 		$8.96K Buy
721
+590
+450% +$7.92K ﹤0.01% 2798
2025
Q4 		$1.65K Hold
131
– – ﹤0.01% 3183
2025
Q3 		$1.31K Hold
131
– – ﹤0.01% 3152
2025
Q2 		$1.06K Hold
131
– – ﹤0.01% 3184
2025
Q1 		$1.1K Buy
131
+100
+323% +$835 ﹤0.01% 3099
2024
Q4 		$246 Hold
31
– – ﹤0.01% 3349
2024
Q3 		$258 Hold
31
– – ﹤0.01% 3260
2024
Q2 		$197 Hold
31
– – ﹤0.01% 3207
2024
Q1 		$188 Hold
31
– – ﹤0.01% 3158
2023
Q4 		$188 Buy
+31
New +$138 ﹤0.01% 3179
2022
Q4 		– Sell
-60
Closed – – 3352
2022
Q3 		$0 Buy
+60
New +$168 ﹤0.01% 3120
2021
Q4 		– Sell
-84
Closed – – 3059
2021
Q3 		$0 Buy
+84
New +$423 ﹤0.01% 3053
2019
Q3 		– Sell
-26
Closed – – 2389
2019
Q2 		$0 Hold
26
– – ﹤0.01% 2308
2019
Q1 		$0 Sell
26
-280
-92% -$3.7K ﹤0.01% 2280
2018
Q4 		$4K Hold
306
– – ﹤0.01% 1633
2018
Q3 		$7K Buy
+306
New +$6.44K ﹤0.01% 1556

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFC
Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Parallel Advisors's AMRX Position: Q2 2026 in Review

Parallel Advisors reduced its Amneal Pharmaceuticals (AMRX) stake by 0.97% in Q2 2026, selling an estimated $96 and leaving 714 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2843.

Parallel Advisors first reported a position in AMRX in Q3 2018 and has held it in 17 quarters since. 123 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Parallel Advisors held 714 shares of Amneal Pharmaceuticals worth $12.4K as of Q2 2026.
  • Parallel Advisors sold 7 Amneal Pharmaceuticals shares in Q2 2026, an estimated $96.
  • Amneal Pharmaceuticals made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2843 holding.
  • Parallel Advisors first reported a position in Amneal Pharmaceuticals in Q3 2018 and has held it in 17 quarters since.
  • 123 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.